loadpatents
Patent applications and USPTO patent grants for PAUL; Sibasish.The latest application filed is for "synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry".
Patent | Date |
---|---|
Synthesis Of Backbone Modified Morpholino Oligonucleotides And Chimeras Using Phosphoramidite Chemistry App 20220144867 - CARUTHERS; Marvin ;   et al. | 2022-05-12 |
Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry Grant 11,230,565 - Caruthers , et al. January 25, 2 | 2022-01-25 |
Thiomorpholino Oligonucleotides For The Treatment of Muscular Dystrophy App 20200308586 - Caruthers; Marvin ;   et al. | 2020-10-01 |
Synthesis Of Backbone Modified Morpholino Oligonucleotides And Chimeras Using Phosphoramidite Chemistry App 20190218236 - CARUTHERS; Marvin ;   et al. | 2019-07-18 |
Morpholino-based antisense agent Grant 9,914,745 - Sinha , et al. March 13, 2 | 2018-03-13 |
Morpholino-based Antisense Agent App 20120296087 - Sinha; Surajit ;   et al. | 2012-11-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.